IPCA LABORATORIES UK LIMITED

Company number

04951981

Status

Active

Incorporation

2003-11-04

Last accounts made up

2025-03-31

Account category

GROUP

Primary SIC

21200

Hubs

UK Healthcare

Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers

Accounting basis

FRS 102

Reporting scope

Consolidated (group)

Auditor

Leesing Marrison Lee Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Subsidiaries

• Onyx Scientific Limited · 100% held

Significant events

• “Based upon the current order position, the directors are confident that the group will continue to increase sales and profitability.”
• “A loss of a key business system could impact our ability to manufacture products and lead to customer disappointment and reputational damage. Ipca mitigates this risk through investment in robust security controls and procedures, security testing arrangements and ongoing employee training.”
• “The timing of drug approval by government agencies may affect the phasing of sales. The company continues to mitigate this risk by the expansion and diversification of its customer base and product portfolios.”
• “The group is exposed to credit risk from its trade debtors and from depositing cash with banking institutions. Customers are assessed for credit-worthiness before credit is extended, and any debts which become overdue are chased promptly. likewise, the company only engages with banks that can demonstrate a strong financial position and developments in the sector are monitored closely.”
• “The group has faced an increase in its cost base due to inflationary pressures the UK has recently experienced. This, coupled with current global financial uncertainty together exert uncontrollable pressure on the company's profitability.”

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers